Results 171 to 180 of about 53,199 (230)

Spheroid cultures reveal cancer stem cell enrichment and distinct chemotherapeutic response in triple-negative breast cancer. [PDF]

BMC Cancer
Sarathchandra S, Fittipaldi C, Alamukii NA, Kovács A, Parris TZ.   +4 more
europepmc   +1 more source

Interim analysis in clinical trials: caution against premature conclusions-the SWOG multiple myeloma S0777 case study. [PDF]

Trials
Goren E, Sexton R, Orlowski RZ, Hoering A.   +3 more
europepmc   +1 more source

Advances in Modeling Multiple Myeloma Within the Bone Marrow Tumor Microenvironment for Exploration of Current and Emerging Therapies. [PDF]

Cancers (Basel)
Toomes CEJ, Best OG, Hollenberg T, Turner R, Bonder CS, McClure BJ.   +5 more
europepmc   +1 more source

Histopathological improvement in kidney AL amyloid deposits following daratumumab-based chemotherapy and autologous peripheral blood stem cell transplantation: a case report. [PDF]

CEN Case Rep
Hirashio S, Ohnari S, Kadono M, Shimomura T, Tachiyama Y, Masaki T.   +5 more
europepmc   +1 more source

Diagnostic discordance in amyloidosis: lessons from proteomic amyloid typing. [PDF]

Clin Kidney J
da Silva ML, Pais T, Boavida J, Branco C, Pinheiro P, Justino G, Lopes JA, Rodrigues N.   +7 more
europepmc   +1 more source

Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study. [PDF]

Front Oncol
Quintero G, Aruachan S, Figueroa Emiliani J, Galvez K, Salazar LA, Otero Venegas C, Buitrago D, Martínez-Cordero H, Saavedra J, Vargas MF.   +9 more
europepmc   +1 more source

Predictive value of endothelial activation and stress index for acute kidney injury in hospitalized patients with multiple myeloma. [PDF]

Am J Transl Res
Wang G, Zhu Y, Yan X, Xu L, Wang J, Liu J, Yu L.   +6 more
europepmc   +1 more source

Celiac Disease Emerging After ASCT in Multiple Myeloma: A Rare Diagnostic Intersection and Literature Review. [PDF]

Case Rep Hematol
Musleh M, Alswij MA, Alhusein Q.
europepmc   +1 more source

Effect of daratumumab on patients with high-risk cytogenetic multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Immunol
Su L, Ye M, Peng B, Fan L, Wu J.
europepmc   +1 more source

Superior 12-month progression-free survival with frontline DVd versus VRd in patients with newly diagnosed multiple myeloma: a multicenter propensity score-matched analysis. [PDF]

J Transl Med
Jiang H, Li Q, Wang L, Dou X, Leng Q, Miao M, Yang Y, Zhang M, Li Y, Li J, Zhang R, Lv Y, Liu Z, Wang H, Li Y, Li R, Zhang R, Tian F, Jiang Y, Wang J, Wang M, Wang X, He X, Lu J, Liao A.   +24 more
europepmc   +1 more source